Return On Equity
153%
Trailing 12 months · Through 31 Mar 2023
YoY relative change: +321%
AMYRIS, INC. financial metrics
Period Q1 2023 · Filed not available
Key metrics snapshot
Return On Assets
-80%
Trailing 12 months · Through 31 Mar 2023
YoY relative change: +460%
Current Ratio
0.52x
Period-end balance · Through 31 Mar 2023
YoY relative change: -71%
Quick Ratio
0.29x
Period-end balance · Through 31 Mar 2023
YoY relative change: -80%
Debt-to-equity
-2.6x
Period-end balance · Through 31 Mar 2023
YoY relative change: -89%
Profitability
| Metric | Latest value | YoY relative change |
|---|---|---|
| Return On Equity |
153%
Trailing 12 months · 31 Mar 2023
|
+321% |
| Return On Assets |
-80%
Trailing 12 months · 31 Mar 2023
|
+460% |
Financial Health
| Metric | Latest value | YoY relative change |
|---|---|---|
| Current Ratio |
0.52x
Period-end balance · 31 Mar 2023
|
-71% |
| Quick Ratio |
0.29x
Period-end balance · 31 Mar 2023
|
-80% |
| Debt-to-equity |
-2.6x
Period-end balance · 31 Mar 2023
|
-89% |
Share Metrics
| Metric | Latest value | YoY relative change |
|---|---|---|
| Entity Common Stock, Shares Outstanding |
366,251,614
Period-end balance · 14 Mar 2023
|
+15% |
| Common Stock, Shares, Outstanding |
368,524,240
Period-end balance · 31 Mar 2023
|
+19% |
| Common Stock, Value, Issued |
$37,000
Period-end balance · 31 Mar 2023
|
+16% |
| Weighted Average Number of Shares Outstanding, Basic |
365,603,738
Reported period · 31 Mar 2023
|
+17% |
| Weighted Average Number of Shares Outstanding, Diluted |
365,603,738
Reported period · 31 Mar 2023
|
+13% |
Supporting Metrics
These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.
| Metric | Latest value | YoY relative change |
|---|---|---|
| Accounts Payable, Current |
$200,067,000
Period-end balance · 31 Mar 2023
|
+127% |
| Accrued Liabilities, Current |
$81,068,000
Period-end balance · 31 Mar 2023
|
+0.64% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax |
-$56,682,000
Period-end balance · 31 Mar 2023
|
-51% |
| Additional Paid in Capital |
$2,465,802,000
Period-end balance · 31 Mar 2023
|
|
| Amortization of Intangible Assets |
$4,877,000
Trailing 12 months · 31 Mar 2023
|
+160% |
| Assets |
$679,679,000
Period-end balance · 31 Mar 2023
|
-24% |
| Assets, Current |
$243,661,000
Period-end balance · 31 Mar 2023
|
-48% |
| Cash and Cash Equivalents, at Carrying Value |
$11,245,000
Period-end balance · 31 Mar 2023
|
-96% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$17,451,000
Period-end balance · 31 Mar 2023
|
-94% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-$53,147,000
Reported period · 31 Mar 2023
|
+73% |
| Common Stock, Par or Stated Value Per Share |
0
Period-end balance · 31 Mar 2023
|
0% |
| Common Stock, Shares Authorized |
550,000,000
Period-end balance · 31 Mar 2023
|
+22% |
| Common Stock, Shares, Issued |
368,524,240
Period-end balance · 31 Mar 2023
|
+16% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-$633,747,000
Trailing 12 months · 31 Mar 2023
|
-744% |
| Contract with Customer, Liability, Current |
$33,000
Period-end balance · 31 Mar 2023
|
-98% |
| Costs and Expenses |
$898,173,000
Trailing 12 months · 31 Mar 2023
|
+45% |
| Depreciation, Depletion and Amortization |
$4,527,000
Reported period · 31 Mar 2023
|
+89% |
| Earnings Per Share, Basic |
-2
Trailing 12 months · 31 Mar 2023
|
-868% |
| Earnings Per Share, Diluted |
-2
Trailing 12 months · 31 Mar 2023
|
-612% |
| Employee-related Liabilities, Current |
$23,308,000
Period-end balance · 31 Mar 2023
|
+109% |
| Goodwill |
$50,456,000
Period-end balance · 31 Mar 2023
|
-63% |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest |
-$630,997,000
Trailing 12 months · 31 Mar 2023
|
-584% |
| Income Tax Expense (Benefit) |
-$2,737,000
Trailing 12 months · 31 Mar 2023
|
+70% |
| Increase (Decrease) in Accounts Receivable |
-$5,288,000
Reported period · 31 Mar 2023
|
-440% |
| Intangible Assets, Net (Excluding Goodwill) |
$45,063,000
Period-end balance · 31 Mar 2023
|
-20% |
| Interest Expense |
$32,453,000
Trailing 12 months · 31 Mar 2023
|
+30% |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$1,567,000
Reported period · 31 Mar 2023
|
+2913% |
| Inventory, Net |
$109,021,000
Period-end balance · 31 Mar 2023
|
+32% |
| Lessee, Operating Lease, Liability, to be Paid |
$334,928,000
Period-end balance · 31 Mar 2023
|
+235% |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$25,888,000
Period-end balance · 31 Mar 2023
|
+189% |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$23,808,000
Period-end balance · 31 Mar 2023
|
+105% |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$24,649,000
Period-end balance · 31 Mar 2023
|
+175% |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$23,361,000
Period-end balance · 31 Mar 2023
|
+155% |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$241,458,000
Period-end balance · 31 Mar 2023
|
+341% |
| Liabilities |
$1,327,747,000
Period-end balance · 31 Mar 2023
|
+30% |
| Liabilities and Equity |
$679,679,000
Period-end balance · 31 Mar 2023
|
-24% |
| Liabilities, Current |
$470,794,000
Period-end balance · 31 Mar 2023
|
+77% |
| Net Cash Provided by (Used in) Financing Activities |
$41,614,000
Reported period · 31 Mar 2023
|
+951% |
| Net Cash Provided by (Used in) Investing Activities |
-$4,815,000
Reported period · 31 Mar 2023
|
+90% |
| Net Cash Provided by (Used in) Operating Activities |
-$90,001,000
Reported period · 31 Mar 2023
|
+41% |
| Nonoperating Income (Expense) |
-$1,045,000
Trailing 12 months · 31 Mar 2023
|
-100% |
| Operating Income (Loss) |
-$629,952,000
Trailing 12 months · 31 Mar 2023
|
-59% |
| Operating Lease, Liability |
$93,470,000
Period-end balance · 31 Mar 2023
|
+107% |
| Operating Lease, Liability, Current |
$2,484,000
Period-end balance · 31 Mar 2023
|
-69% |
| Operating Lease, Liability, Noncurrent |
$90,986,000
Period-end balance · 31 Mar 2023
|
+146% |
| Operating Lease, Payments |
$4,620,000
Reported period · 31 Mar 2023
|
+52% |
| Operating Lease, Right-of-Use Asset |
$100,721,000
Period-end balance · 31 Mar 2023
|
+71% |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.23
Period-end balance · 31 Mar 2023
|
+21% |
| Other Assets, Current |
$5,012,000
Period-end balance · 31 Mar 2023
|
+36% |
| Other Assets, Noncurrent |
$13,662,000
Period-end balance · 31 Mar 2023
|
-42% |
| Other Liabilities, Noncurrent |
$5,725,000
Period-end balance · 31 Mar 2023
|
+64% |
| Property, Plant and Equipment, Gross |
$297,959,000
Period-end balance · 31 Mar 2023
|
+35% |
| Property, Plant and Equipment, Net |
$189,645,000
Period-end balance · 31 Mar 2023
|
+51% |
| Research and Development Expense |
$110,622,000
Trailing 12 months · 31 Mar 2023
|
+14% |
| Retained Earnings (Accumulated Deficit) |
-$3,073,520,000
Period-end balance · 31 Mar 2023
|
-25% |
| Share-based Payment Arrangement, Expense |
$42,908,000
Trailing 12 months · 31 Mar 2023
|
+5.4% |
| Share-based Payment Arrangement, Noncash Expense |
$5,785,000
Reported period · 31 Mar 2023
|
-50% |
| Stockholders' Equity Attributable to Parent |
-$664,363,000
Period-end balance · 31 Mar 2023
|
-318% |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
-$674,126,000
Period-end balance · 31 Mar 2023
|
-315% |
Comparisons, sources and research notes
Sources and sharing
AMYRIS, INC. Financial Facts
- Context
- Latest metrics period: Q1 2023
- Latest reported value
- Return On Equity 153%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
Tracking and update notes
Why revisit this company facts page
Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.
- Latest source-backed update
- Latest metrics period Q1 2023
- Why come back
- Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
- Current latest metrics period: Q1 2023.
- Most recent SEC facts end date on this page: 31 Mar 2023.
- Save this filer to return when the next filing-backed metric period changes the picture.
Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.
Benchmark Context
How Return On Equity compares
Return On Equity is up about 321% versus the comparable prior period.
Compared with
Compared with AMYRIS, INC.'s recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.
Why this is notable
Return On Equity already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.
- Latest comparable period on this page: Q1 2023.
- Peer context will appear when enough companies report a comparable value for this metric.
- Open the metric history first if you want to verify the exact period-to-period change.
Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.
Filing notes and source
Key facts
- AMYRIS, INC. financial facts use SEC filings; any third-party reference is labeled separately.
- Latest metrics period on this page: Q1 2023.
- Headline metric: Return On Equity 153%.
Change
- Return On Equity YoY relative change: +321%.
- Most recent SEC facts end date: 31 Mar 2023.
Research use
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Metric cards link to SEC history; a third-party reference may use a different or unverified reporting period.
Evidence
Based on latest 10-Q/10-K
View source filing
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Latest financial snapshot (2023-03-31) highlights Return On Equity 152.6%, Return On Assets -79.6%, and Current Ratio 0.52x.
Valuation Snapshot
SEC-only DCF estimate using a normalized free cash flow base, cash, debt, and reported share count when available.
No market comparison
USD inputs only. Cash and complete debt must share the latest balance date. Missing balances are unknown, never zero; equity value and market EV remain unavailable until both are verified.
DCF estimate is unavailable because required valuation inputs are missing.
Missing: Free cash flow.
Input periods, units and SEC sources
Equity value = DCF enterprise value + cash − debt. Cash flow uses matching annual or trailing-12-month periods.
- Operating cash flow: -463,453,000.0 USD · through 2023-03-31 · prior annual + current YTD − prior YTD SEC source SEC source SEC source
- Capital expenditures: unavailable on a verified comparable basis
- Cash and equivalents: 11,245,000.0 USD · through 2023-03-31 SEC source
- Debt: 882,100,000.0 USD · through 2023-03-31 · Borrowings excluding leases SEC source
Data confidence notes
- Free cash flow unavailable: matching usd annual or trailing-12-month operating cash flow and cash capex are required
- Ticker missing for issuer
- Valuation unavailable: free cash flow is missing
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
43.8/100
Caution Confidence medium
Return On Equity
153%
Metric score 100.0/100
Return On Assets
-80%
Metric score 0.0/100
Financial Health
- Current Ratio
- 0.52x
- Quick Ratio
- 0.29x
- Debt to Equity
- -2.6x
Strengths
Return On Equity
Watchpoints
Return On Assets, Quick Ratio, and Debt-to-equity
Calculation methodology and other links
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- Operating Income / Revenues using matching TTM or quarter periods; basis shown per metric
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- Revenues YoY using available TTM or quarter comparison; basis shown per metric
- Net Income YoY using available TTM or quarter comparison; basis shown per metric
CIK / security context first